ARTICLE | Company News
Intas Pharmaceuticals sales and marketing update
March 9, 2015 7:00 AM UTC
Intas’ Accord Healthcare subsidiary launched Accofil, a biosimilar of neutropenia drug Neupogen filgrastim, in the EU. Filgrastim is a recombinant methionyl human G-CSF. Amgen Inc. (NASDAQ:AMGN, Th...